Updated:
Sanofi Sunrise
Sanofi Sunrise was established to steward wealth originating from the Sanofi pharmaceutical empire, one of Europe's largest drug companies.
Sanofi Sunrise
Sanofi Sunrise was established to steward wealth originating from the Sanofi pharmaceutical empire, one of Europe's largest drug companies. The firm maintains dual headquarters in San Francisco and Paris, reflecting a transatlantic investment mandate. The office invests across private equity, venture capital, and real assets, with a pronounced emphasis on healthcare and life sciences. Known portfolio exposure includes direct co-investments in biotechnology and medical-device startups, as well as fund commitments to specialist healthcare managers. Geographic focus spans North America and Europe, with occasional deals in Asia. Team size and total assets under management are not publicly disclosed. The firm maintains a lean internal team, supplemented by external advisors. No recent operational events have been reported in public filings or press coverage. The structure of Sanofi Sunrise as a single-family office linked to a pharmaceutical fortune creates a long-term, capital-persistent profile. Investment decisions are made by family principals, with no external LP base or fund structure, allowing for patient deployment across illiquid asset classes.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, CA, United States
Additional offices
Paris, France
Sector focus
Frequently asked questions
Who runs investment decisions at Sanofi Sunrise?
Sanofi Sunrise is a single-family office managed by family principals from the Sanofi lineage. Specific names of investment decision-makers are not publicly disclosed.
What is the investment strategy of Sanofi Sunrise?
The office targets direct investments and fund commitments primarily in healthcare and life sciences, along with private equity and real assets. It focuses on both venture-stage and growth-stage opportunities, with a transatlantic geographic scope.
Does Sanofi Sunrise have any relationship with Sanofi the pharmaceutical company?
Yes, the family office manages wealth generated by the Sanofi pharmaceutical dynasty. However, it operates independently from the company's corporate treasury or R&D budget, with separate investment governance.
Where does Sanofi Sunrise invest geographically?
The firm invests primarily in North America and Europe, leveraging offices in San Francisco and Paris. Deals occasionally extend into Asia, based on sector-specific opportunities.
How does Sanofi Sunrise source proprietary deal flow?
The office relies on its network of family relationships, industry connections in pharmaceuticals, and co-investment relationships with established private equity and venture capital firms. Specific sourcing mechanisms are not detailed publicly.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: